申请人:Bristol-Myers Squibb Company
公开号:US20140235672A1
公开(公告)日:2014-08-21
The present application describes modulators of MCP-1 or CCR-2 of formula
or stereoisomers or prodrugs or pharmaceutically acceptable salts thereof, wherein W
1
, W
2
, W
3
, Y, Z, R
2
, R
3
, R
3′
and R
4
, are defined in the specification. In addition, methods of treating and preventing inflammatory diseases such as asthma and allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis and transplant rejection using modulators of formula (I) are disclosed.
本申请描述了 MCP-1 或 CCR-2 的调节剂的公式或立体异构体或前药或其药学上可接受的盐,其中 W1、W2、W3、Y、Z、R2、R3、R3'和R4在规范中定义。此外,本申请还揭示了使用公式(I)的调节剂治疗和预防炎症性疾病,如哮喘和过敏性疾病,以及自身免疫病理,如类风湿性关节炎和移植排斥等方法。